Compounded Melasma and Hyperpigmentation Formulations

Melasma is a common pigmentation disorder that causes brown or gray-brown patches on the skin, most often on the face. It is significantly more common in women and is closely tied to hormonal changes including pregnancy, oral contraceptive use and hormone therapy, as well as UV exposure. Because melanin production involves multiple biochemical pathways, melasma is typically most effectively managed with a multi-ingredient approach that addresses several of those pathways simultaneously. Compounded melasma formulations allow healthcare providers to prescribe specific combinations of active ingredients at concentrations suited to each patient’s skin tone, pigmentation severity and history. Active ingredients commonly incorporated into compounded melasma preparations include hydroquinone for inhibiting melanin production, tretinoin for supporting cell turnover and enhancing ingredient penetration, kojic acid and azelaic acid for complementary melanin-inhibiting effects, niacinamide for tone and barrier support, tranexamic acid for its studied role in reducing pigmentation and corticosteroids at low concentrations when appropriate. Ascorbic acid and other antioxidants may also be incorporated. Consistent broad-spectrum sun protection is an essential part of any melasma management plan regardless of other approaches being used. Pharmacy Solutions is a PCAB-accredited 503A compounding pharmacy that works with dermatologists and other providers nationwide to prepare individualized melasma formulations. The RX Skin Solutions line and EltaMD sunscreens are also available without a prescription through the Pharmacy Solutions shop.